Cargando…

The Microenvironment in Epstein–Barr Virus-Associated Malignancies

The Epstein–Barr virus (EBV) can cause a wide variety of cancers upon infection of different cell types and induces a highly variable composition of the tumor microenvironment (TME). This TME consists of both innate and adaptive immune cells and is not merely an aspecific reaction to the tumor cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Geok Wee, Visser, Lydia, Tan, Lu Ping, van den Berg, Anke, Diepstra, Arjan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027429/ https://www.ncbi.nlm.nih.gov/pubmed/29652813 http://dx.doi.org/10.3390/pathogens7020040

Ejemplares similares

The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein–Barr virus presence and location within the tumor
por: Wu, R, et al.
Publicado: (2016)

Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China
por: Huang, Xin, et al.
Publicado: (2011)

Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma
por: Visser, Lydia, et al.
Publicado: (2016)

Erratum: Lydia Visser et al. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma, Int. J. Mol. Sci. 2016, 17, 2127
por: Sattarzadeh, Ahmad, et al.
Publicado: (2018)

Toll-like receptors in the pathogenesis of human B cell malignancies
por: Isaza-Correa, Johana M, et al.
Publicado: (2014)

Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
por: Zheng, Xueyi, et al.
Publicado: (2022)

Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies
por: Xu, Miao, et al.
Publicado: (2019)

CD57+ T-cells are a subpopulation of T-follicular helper cells in nodular lymphocyte predominant Hodgkin lymphoma
por: Sattarzadeh, Ahmad, et al.
Publicado: (2015)

Molecular Genetics in Epstein–Barr Virus-Associated Malignancies
por: Umakanthan, Srikanth, et al.
Publicado: (2021)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
por: de Mel, Sanjay, et al.
Publicado: (2019)

The role of Epstein–Barr virus in epithelial malignancies
por: Tsao, Sai-Wah, et al.
Publicado: (2015)

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
por: Bauer, Marcus, et al.
Publicado: (2021)

HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
por: Tan, Geok Wee, et al.
Publicado: (2021)

PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV+ Hodgkin Lymphoma
por: Liu, Yuxuan, et al.
Publicado: (2013)

Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies
por: Ghosh, Sajal K., et al.
Publicado: (2012)

Epstein–Barr Virus-Associated Malignancies: Roles of Viral Oncoproteins in Carcinogenesis
por: El-Sharkawy, Ahmed, et al.
Publicado: (2018)

The Hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-Barr virus?
por: Tan, Mark T. L., et al.
Publicado: (2019)

Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma
por: Liang, Zheng, et al.
Publicado: (2014)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

Soluble PD‐L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma
por: Veldman, Johanna, et al.
Publicado: (2021)

An Epstein-Barr virus-associated superantigen
Publicado: (1996)

Epstein–Barr virus-associated lymphomas
por: Shannon-Lowe, Claire, et al.
Publicado: (2017)

The Association of Epstein-Barr Virus With Cancer
por: Patel, Pragnesh D, et al.
Publicado: (2022)

EPSTEIN-BARR VIRUS-NEGATIVE HUMAN MALIGNANT T-CELL LINES
por: Kaplan, Joseph, et al.
Publicado: (1974)

Epstein-Barr virus associated posttransplant malignant lymphoma in renal allograft recipients.
por: Choi, Y. J., et al.
Publicado: (1994)

EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOID MALIGNANCIES: THE EXPANDING SPECTRUM OF HEMATOPOIETIC NEOPLASMS
por: KIMURA, HIROSHI, et al.
Publicado: (2013)

Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
por: Chen, Ruyue, et al.
Publicado: (2023)

Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma
por: Lee, Jae Myun, et al.
Publicado: (2011)

The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
por: Zhang, Jinglin, et al.
Publicado: (2017)

Evaluation of plasma Epstein–Barr virus DNA as a biomarker for Epstein–Barr virus–associated Hodgkin lymphoma
por: Usha, Masuma Khatun, et al.
Publicado: (2021)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

Molecular Epidemiology of Epstein-Barr virus (EBV) in Patients with Hematologic Malignancies
por: Tabibzadeh, Alireza, et al.
Publicado: (2020)

Chronic Active Epstein–Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both?
por: Fujiwara, Shigeyoshi, et al.
Publicado: (2020)

Epstein–Barr virus-associated nephrotic syndrome
por: Mikhalkova, Deana, et al.
Publicado: (2012)

Epstein Barr Virus-Associated Hodgkin Lymphoma
por: Carbone, Antonino, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eg5adlk0tkhdbct8ksgl8pi7dk